Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Ocular Therapeutix Inc has a consensus price target of $16.22 based on the ratings of 9 analysts. The high is $22 issued by Scotiabank on October 16, 2024. The low is $11 issued by TD Cowen on June 20, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Scotiabank on December 3, 2024, November 15, 2024, and October 16, 2024, respectively. With an average price target of $17.33 between HC Wainwright & Co., HC Wainwright & Co., and Scotiabank, there's an implied 80.18% upside for Ocular Therapeutix Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Ocular Therapeutix (NASDAQ:OCUL) was reported by HC Wainwright & Co. on December 3, 2024. The analyst firm set a price target for $15.00 expecting OCUL to rise to within 12 months (a possible 55.93% upside). 22 analyst firms have reported ratings in the last year.
The latest analyst rating for Ocular Therapeutix (NASDAQ:OCUL) was provided by HC Wainwright & Co., and Ocular Therapeutix reiterated their buy rating.
The last upgrade for Ocular Therapeutix Inc happened on June 20, 2024 when TD Cowen raised their price target to $11. TD Cowen previously had a hold for Ocular Therapeutix Inc.
There is no last downgrade for Ocular Therapeutix.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocular Therapeutix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocular Therapeutix was filed on December 3, 2024 so you should expect the next rating to be made available sometime around December 3, 2025.
While ratings are subjective and will change, the latest Ocular Therapeutix (OCUL) rating was a reiterated with a price target of $15.00 to $15.00. The current price Ocular Therapeutix (OCUL) is trading at is $9.62, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.